eNews
Home page > Comments


Comments

Novartis' vaccines business gets chance to prove itself

17.11.2012. | ZURICH (Reuters) - The European Medicines Agency has thrown Novartis' loss-making vaccines business a lifeline by recommending its meningitis B shot for approval, which means the pressure is on to make the product a commercial success....


Оставите Ваш коментр
*Име:

Е-пошта:


*Ваш коментар:
:) :D ;) B-) :P :-o :( x-(

*Сигурносни број: